stockportfolio.pro
ICLR vs TECH: Which Stock Is the Better Buy?
ICON Public Limited Company and Bio-Techne Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — ICLR vs TECH, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| ICON Public Limited Company (ICLR) | Bio-Techne Corporation (TECH) | |
|---|---|---|
| Market cap | $11.1B | $11.0B |
| Revenue (latest FY) | $8.25B | $1.22B |
| Net income (latest FY) | $229.34M | $73.40M |
| Revenue growth (5y CAGR) | 2.1% | 10.5% |
| Net margin | 2.8% | 6.0% |
| Return on equity | 2.5% | 3.8% |
| P/E ratio | 50.0 | 101.2 |
| Dividend yield | — | 0.4% |
| Profitable years (of last 10) | 4 | 10 |
| Positive free cash flow | Yes | Yes |
See the full ICLR vs TECH breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open ICLR's full financials → Open TECH's full financials →More comparisons
Frequently asked questions
Which is bigger, ICLR or TECH?
ICON Public Limited Company is larger by market capitalization — $11.1B versus $11.0B.
Which grows faster, ICLR or TECH?
Over the last five fiscal years, Bio-Techne Corporation grew revenue faster — 10.5%/yr versus 2.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.